USE OF RITUXIMAB FOR THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF RHEUMATOID ARTHRITIS AND ITS ADMINISTRATION REGIME

摘要

The Present application describes therapy with antagonists which bind to B cell surface markers, such as CD20. In particular, the application describes the use of such antagonists to treat autoimmune disease in a mammal who experiences an inadequate response to a TNF-± inhibitor.